Combinatorial immunotherapy with anti-ROR1 CAR NK cells and an IL-21 secreting oncolytic virus against neuroblastoma. [PDF]
Chu Y+12 more
europepmc +1 more source
Engineered oncolytic virus expressing B7H3-targeting BiTE enhances antitumor T-cell immune response. [PDF]
Zhu H+5 more
europepmc +1 more source
Mitochondrial metabolic reprogramming of macrophages and T cells enhances CD47 antibody-engineered oncolytic virus antitumor immunity. [PDF]
Zhao J+7 more
europepmc +1 more source
A Novel Chimeric Oncolytic Virus Mediates a Multifaceted Cellular Immune Response in a Syngeneic B16 Melanoma Model. [PDF]
Glauß S+6 more
europepmc +1 more source
Oncolytic virus OH2 extends survival in patients with PD-1 pretreated melanoma: phase Ia/Ib trial results and biomarker insights. [PDF]
Wang X+19 more
europepmc +1 more source
Dose Considerations for Vaccinia Oncolytic Virus Based on Retrospective Reanalysis of Early and Late Clinical Trials. [PDF]
Cyrelle Ornella MS+4 more
europepmc +1 more source
Synergistic effects of herpes oncolytic virus and cyclophosphamide for recurrent malignant glioma: a narrative review. [PDF]
Iqbal J+9 more
europepmc +1 more source
Editorial: Recent advances in gene modified immune cells and oncolytic virus for cancer immunotherapy. [PDF]
Yuan C, Wang Y, Guo ZS.
europepmc +1 more source
Single-cell data-driven design of armed oncolytic virus to boost cooperative innate-adaptive immunity against cancer. [PDF]
Zhao J+26 more
europepmc +1 more source